|Articles|September 1, 2019
- BioPharm International-09-01-2019
- Volume 32
- Issue 9
BioPharm International, September 2019 Issue (PDF)
Click the title above to open the BioPharm International September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Improving Oligonucleotide Analysisabout 6 years ago
Dealing with particulates or aggregates in biologicsabout 6 years ago
Putting Biopharma Stability Testing Under the Microscopeabout 6 years ago
What’s New in Manufacturing: Process Chromatographyabout 6 years ago
More Predictable Post-Approval Change Policy on Horizonabout 6 years ago
Best Practices for Studying Stability in Biologicsabout 6 years ago
Developing an Effective Contamination Control Strategyabout 6 years ago
Biologics Continue to Grow and Create Outsourcing Opportunitiesabout 6 years ago
Plan Now to Share Your Expertise in 2020Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
